These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32035517)

  • 1. Vaccine boosts: balancing response magnitude and character.
    Crowley AR; Ackerman ME
    Lancet HIV; 2020 Apr; 7(4):e217-e219. PubMed ID: 32035517
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
    Rerks-Ngarm S; Pitisuttithum P; Excler JL; Nitayaphan S; Kaewkungwal J; Premsri N; Kunasol P; Karasavvas N; Schuetz A; Ngauy V; Sinangil F; Dawson P; deCamp AC; Phogat S; Garunathan S; Tartaglia J; DiazGranados C; Ratto-Kim S; Pegu P; Eller M; Karnasuta C; Montefiori DC; Sawant S; Vandergrift N; Wills S; Tomaras GD; Robb ML; Michael NL; Kim JH; Vasan S; O'Connell RJ;
    J Infect Dis; 2017 Apr; 215(8):1255-1263. PubMed ID: 28329190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
    Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
    J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
    Karnasuta C; Paris RM; Cox JH; Nitayaphan S; Pitisuttithum P; Thongcharoen P; Brown AE; Gurunathan S; Tartaglia J; Heyward WL; McNeil JG; Birx DL; de Souza MS;
    Vaccine; 2005 Mar; 23(19):2522-9. PubMed ID: 15752839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.
    Jenkins RA; Chinaworapong S; Morgan PA; Ruangyuttikarn C; Sontirat A; Chiu J; Michael RA; Nitayaphan S; Khamboonruang C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):171-7. PubMed ID: 9637582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers.
    Thapinta D; Jenkins RA; Celentano DD; Nitayaphan S; Buapunth P; Triampon A; Morgan PA; Khamboonruang C; Suwanarach C; Yutabootr Y; Ruckphaopunt S; Suwankiti S; Tubtong V; Cheewawat W; McNeil JG; Michael RA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):308-14. PubMed ID: 10077182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV/AIDS research. Beyond Thailand: making sense of a qualified AIDS vaccine "success".
    Cohen J
    Science; 2009 Oct; 326(5953):652-3. PubMed ID: 19900904
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral AIDS vaccine used in Thailand.
    AIDS Patient Care STDS; 2007 Nov; 21(11):894. PubMed ID: 18338436
    [No Abstract]   [Full Text] [Related]  

  • 9. International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand.
    Phanuphak P; Teeratakulpixarn S; Sarangbin S; Nookhai S; Ubolyam S; Sirivichayakul S; Leesavan A; Forrest BD; Hanson CV; Li M; Wang CY; Koff WC
    Asian Pac J Allergy Immunol; 1997 Mar; 15(1):41-8. PubMed ID: 9251847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand.
    Thapinta D; Jenkins RA; Morgan PA; Chiu J; Boenim W; Bussaratid V; Chaddic C; Naksrisook S; Phonrat B; Sirijongdee N; Sornsathapornkul P; Sontirat A; Srisaengchai P; Suwanarach C; Wongkamhaeng S; Brown AE; Khamboonruang C; Nitayaphan S; Pitisuttithum P; Thongchareon P;
    J Acquir Immune Defic Syndr; 2002 Aug; 30(5):503-13. PubMed ID: 12154341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic vaccine trails in Thailand.
    Churdboonchart V
    J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV vaccine research in Thailand: lessons learned.
    Pitisuttithum P
    Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thailand trial for AIDS therapeutic vaccine?
    Science; 1995 Sep; 269(5228):1207. PubMed ID: 7652565
    [No Abstract]   [Full Text] [Related]  

  • 14. Study released on AIDS vaccine results from Thailand.
    AIDS Alert; 2009 Dec; 24(12):139. PubMed ID: 20063476
    [No Abstract]   [Full Text] [Related]  

  • 15. Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
    Easterhoff D; Moody MA; Fera D; Cheng H; Ackerman M; Wiehe K; Saunders KO; Pollara J; Vandergrift N; Parks R; Kim J; Michael NL; O'Connell RJ; Excler JL; Robb ML; Vasan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; Nitayaphan S; Sinangil F; Tartaglia J; Phogat S; Kepler TB; Alam SM; Liao HX; Ferrari G; Seaman MS; Montefiori DC; Tomaras GD; Harrison SC; Haynes BF
    PLoS Pathog; 2017 Feb; 13(2):e1006182. PubMed ID: 28235027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.
    Agnew B
    Bull World Health Organ; 2004 Mar; 82(3):231. PubMed ID: 15112014
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
    Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
    Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV vaccine: better to start together?
    Felber BK; Pavlakis GN
    Lancet HIV; 2019 Nov; 6(11):e724-e725. PubMed ID: 31601543
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand.
    Rerks-Ngarm S; Brown AE; Khamboonruang C; Thongcharoen P; Kunasol P
    AIDS; 2006 Jul; 20(11):1471-9. PubMed ID: 16847401
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Barouch DH; Tomaka FL; Wegmann F; Stieh DJ; Alter G; Robb ML; Michael NL; Peter L; Nkolola JP; Borducchi EN; Chandrashekar A; Jetton D; Stephenson KE; Li W; Korber B; Tomaras GD; Montefiori DC; Gray G; Frahm N; McElrath MJ; Baden L; Johnson J; Hutter J; Swann E; Karita E; Kibuuka H; Mpendo J; Garrett N; Mngadi K; Chinyenze K; Priddy F; Lazarus E; Laher F; Nitayapan S; Pitisuttithum P; Bart S; Campbell T; Feldman R; Lucksinger G; Borremans C; Callewaert K; Roten R; Sadoff J; Scheppler L; Weijtens M; Feddes-de Boer K; van Manen D; Vreugdenhil J; Zahn R; Lavreys L; Nijs S; Tolboom J; Hendriks J; Euler Z; Pau MG; Schuitemaker H
    Lancet; 2018 Jul; 392(10143):232-243. PubMed ID: 30047376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.